LABU Holdings Information

LABU is an equity ETF with a total of 169 individual holdings.

Total Holdings

169

Top 10 Percentage

78.77%

Asset Class

Equity

ETF Category

Trading--Leveraged Equity

Assets

543.30M

PE Ratio

n/a

Breakdown by Sector

No.	Symbol	Name	% Weight	Shares
1	n/a	Dreyfus Govt Cash Man Ins	22.90%	129,703,884
2	n/a	Goldman Finl Sq Trsry Inst 506	15.56%	88,141,358
3	n/a	S&P Biotechnology Select Industry Index Swap	11.29%	25,717
4	n/a	S&P Biotechnology Select Industry Index Swap	8.80%	23,421
5	n/a	S&P Biotechnology Select Industry Index Swap	6.77%	30,908
6	n/a	S&P Biotechnology Select Industry Index Swap	5.81%	15,766
7	n/a	Goldman Sachs Fin Gov 465 Institut	4.78%	27,092,640
8	n/a	S&P Biotechnology Select Industry Index Swap	1.06%	5,745
9	APGE	Apogee Therapeutics, Inc.	0.92%	38,942
10	n/a	S&P Biotechnology Select Industry Index Swap	0.87%	2,129
11	ERAS	Erasca, Inc.	0.83%	240,922
12	ORKA	Oruka Therapeutics, Inc.	0.82%	50,307
13	KYMR	Kymera Therapeutics, Inc.	0.80%	41,174
14	TWST	Twist Bioscience Corporation	0.79%	47,529
15	DNTH	Dianthus Therapeutics, Inc.	0.76%	42,150
16	VKTX	Viking Therapeutics, Inc.	0.76%	116,076
17	SYRE	Spyre Therapeutics, Inc.	0.75%	42,902
18	PRAX	Praxis Precision Medicines, Inc.	0.74%	13,384
19	PTGX	Protagonist Therapeutics, Inc.	0.73%	30,453
20	RVMD	Revolution Medicines, Inc.	0.72%	22,339
21	MRNA	Moderna, Inc.	0.72%	70,039
22	CGON	CG Oncology, Inc.	0.72%	58,651
23	COGT	Cogent Biosciences, Inc.	0.72%	102,649
24	ARWR	Arrowhead Pharmaceuticals, Inc.	0.71%	45,540
25	PCVX	Vaxcyte, Inc.	0.70%	70,919

Showing 25 of 169 holdings

Subscribe to see the full list

As of Jul 22, 2026